Daniele Santini
Professor
Medical Oncology
Universita Campus Bio-Medico di Roma
Italy
Biography
Daniele Santini from 2016 - present Full Professor, General Pathology, Campus Bio-Medico University of Rome (UCBM); 2014 - present President of the Italian Society of Osteoncology 2010 - present Associate Professor, General Pathology, Campus Bio-Medico University of Rome (UCBM); 2009 - present Responsible, Oncology Day Hospital Single-Speciality Unit, Campus Bio-Medico University Hospital, Rome; 2009 - present Advisor for the prevention of jaw osteonecrosis from bifosfonate, Italian Ministry of Health; 2009 - present Member, Sothern Italia Oncology Group (GOIM); 2008 - present Natinal Council Member, Italian Society of Osteoncology; 2008 - present Coordinator National Guidelines, "Treatment of the Bone Metastasis", Italian Association of Medical Oncology (AIOM)
Research Interest
Hepatocellular carcinoma, Bone metastasis, Colorectal tumors, Kidney tumors, Gastric cancers
Publications
-
Prognostic and predictive role of neutrophils/lymphocytes ratio in metastatic colorectal cancer: A retrospective analysis of the TRIBE study by Gono
-
Biliary tract carcinoma and chronic viral hepatitis in Italy: the GICO (Gruppo Italiano COlangiocarcinoma) experience.
-
Bertani FR, Mozetic P, Fioramonti M, Iuliani M, Santini D, et al. Classification of M1/M2-polarized human macrophages by label-free hyperspectral reflectance confocal microscopy and multivariate analysis. Sci Rep. 2017 Aug 21;7(1):8965. doi: 10.1038/s41598-017-08121-8
-
Denosumab (Xgeva) [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Nov. Available from http://www.ncbi.nlm.nih.gov/books/NBK409947/
-
Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy
